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ABSTRACT
Embryonic stem cells (ESCs) can differentiate into
any given cell type and therefore represent a versa-
tile model to study the link between gene regulation
and differentiation. To quantitatively assess the dy-
namics of enhancer activity during the early stages
of murine ESC differentiation, we analyzed accessi-
ble genomic regions using STARR-seq, a massively
parallel reporter assay. This resulted in a genome-
wide quantitative map of active mESC enhancers,
in pluripotency and during the early stages of dif-
ferentiation. We find that only a minority of acces-
sible regions is active and that such regions are
enriched near promoters, characterized by specific
chromatin marks, enriched for distinct sequence mo-
tifs, and modeling shows that active regions can be
predicted from sequence alone. Regions that change
their activity upon retinoic acid-induced differentia-
tion are more prevalent at distal intergenic regions
when compared to constitutively active enhancers.
Further, analysis of differentially active enhancers
verified the contribution of individual TF motifs to-
ward activity and inducibility as well as their role
in regulating endogenous genes. Notably, the activ-
ity of retinoic acid receptor alpha (RAR) occupied
regions can either increase or decrease upon the
addition of its ligand, retinoic acid, with the direc-
tion of the change correlating with spacing and ori-
entation of the RAR consensus motif and the co-
occurrence of additional sequence motifs. Together,
our genome-wide enhancer activity map elucidates
features associated with enhancer activity levels,
identifies regulatory regions disregarded by compu-
tational prediction tools, and provides a resource for
future studies into regulatory elements in mESCs.
INTRODUCTION
Gene expression in eukaryotic cells is a tightly regulated
process which is a prerequisite for cellular identity. Regu-
lation of transcription is controlled by transcription factors
(TF) and the regulatory genomic elements (enhancers, pro-
moters) they target (1,2). The selective and combinatorial
activation of enhancers in a spatiotemporal manner allows
for the complexity of higher eukaryotic organisms, which
consist of a large number of different highly specialized cells
although they all possess the same genome (3,4). Tradition-
ally, enhancers are defined as the genomic elements that can
control the activity of promoters whereas promoters are the
regions where transcription of genes is initiated. Further,
promoters and enhancer regions can be distinguished and
predicted based on distinct patterns of histone modifica-
tions (HMs) (5). However, recent research indicates that the
function of enhancers and promoters may not always be dis-
tinct as studies have demonstrated that promoters can act as
enhancers for other genes (6–8) and enhancers frequently
give rise to transcripts (9), a feature traditionally associated
with promoter function. The assignment of enhancers to
their target promoters is an important step in elucidating
gene regulation and has been addressed in recent years with
rapidly evolving high-throughput chromatin interaction as-
says (10–12). However, the functional relevance of identified
enhancer-promoter pairs was mainly investigated for indi-
vidual genes or loci (13–19) and remains a largely unsolved
problem at the genome-wide level.
The identification and prediction of enhancers is often
based on indirect measures of activity, such as correlat-
ing HMs and chromatin accessibility (1,20–23). Notably,
some enhancer prediction tools discard promoter regions
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as potential enhancers even though there is evidence show-
ing that promoters can act as enhancers of other genes.
Moreover, enhancer prediction based on these marks gives
rise to myriads of putative enhancers but does not pro-
vide quantitative information regarding their activity. This
is of particular interest, since gene expression is not sub-
ject to an on/off switch type of regulation, but rather the
result of a complex interplay between multiple enhancers,
TFs, and coactivators which can fine-tune gene expres-
sion levels to meet the cell’s current needs. Consequently,
it remains largely unclear which of the thousands of pre-
dicted enhancers are actually functional, how enhancer us-
age changes during differentiation and what features are
conferring distinct activity levels.
Embryonic stem cells (ESCs) are characterized by their
ability to differentiate into any given cell type and there-
fore represent a versatile system to study the link between
gene regulation, differentiation and cellular identity (24,25).
Murine ESCs (mESCs) in the pluripotent state exhibit rel-
atively permissive chromatin, with many accessible regions
which are thought to comprise active mESC enhancers but
also primed enhancers that can be activated at later stages
during differentiation (26,27). The expression of genes in
mESCs is also controlled by transposable elements, for ex-
ample from the ERVK family, that can act as enhancers
that control the expression of associated genes (28–30). The
pluripotency of mESCs and their ability to self-renew criti-
cally depend on the actions of specific TFs including OCT4
and SOX2, NANOG, KLF4 and ESRRB (25,31). All these
TFs can bind and activate promoters as well as enhancers
of pluripotency-associated genes in ESCs (27). mESCs can
be cultivated in the pluripotent state when leukemia in-
hibitory factor (LIF) is added to the media to activate the
STAT3 pathway (32), which in turn promotes c-MYC ex-
pression and transcriptional programs important for self-
renewal (33).
Differentiation of ESCs can be used to study the molecu-
lar mechanisms that underly cellular commitment decisions
with potential therapeutic relevance. A highly efficient, yet
simple, protocol to induce cellular differentiation is to treat
mESCs with all-trans retinoic acid (RA) (34). Treatment
with RA induces exit from pluripotency, marks a phase of
increased susceptibility to lineage-defining signals (35) and
ultimately pushes mESCs towards the neuronal lineage (36).
RA is the ligand of retinoic acid receptors (RARs), which
together with retinoid X receptors (RXRs) bind to genomic
response elements and drive expression of differentiation-
associated genes but also repression of genes involved in
pluripotency (37).
In recent years, several studies applying massive parallel
reporter assays based on STARR-seq (38) have been con-
ducted to assess enhancer function of candidate regions in
different species and cell types (6,39–45). In STARR-seq,
the regulatory activity of candidate sequences is measured
by placing them downstream of a minimal promoter to
assess their ability to activate their own expression. Here,
we developed a modified quantitative STARR-seq proto-
col to assess the activity of accessible chromatin isolated
by FAIRE (formaldehyde assisted isolation of regulatory
elements). By focusing on accessible chromatin, we could
reduce the complexity of the investigated fragment library
while retaining regions of interest, specifically promoter and
enhancer regions, as candidate enhancers.
Overall, this allowed us not only to identify active en-
hancers genome-wide in mESCs, but also to quantify en-
hancer activity and thus to identify features, such as se-
quence motifs and their quantities, that correlate with en-
hancer activity. We demonstrate the versatility of our data
by characterizing enhancer subsets with atypical HM pat-
terns and by showing how the underlying sequence of en-
hancers can be used to build an enhancer classifier. More-
over, we used our quantitative approach to identify en-
hancers that change their activity during the early stages of
differentiation. Additionally, we used our data set to char-
acterize ‘functional’ TF binding sites by intersecting RAR
binding sites with RA-induced changes in enhancer activity.
This resulted in the identification of sequence features asso-
ciated with RAR binding events with distinct changes in
enhancer activity. Together, these examples illustrate how
our enhancer activity data can be used as a resource to study
various aspects of gene regulation and mESC differentia-
tion.
MATERIALS AND METHODS
mESC culture and differentiation
E14 mESCs were cultured under feeder-free conditions and
routinely passaged every two days in ES-medium: Glas-
gow Minimum Essential Medium (Sigma-Aldrich) supple-
mented with 17% FBS (Hyclone™, SV30160.03, GE Health-
care), 2 mM GlutaMAX™ (Gibco), 100 U/ml Penicillin–
Streptomycin (Gibco), 1× MEM Non-Essential Amino
Acid Solution (Gibco), 1 mM Sodium Pyruvate (Gibco),
0.5 mM 2-Mercaptoethanol (Gibco) and recombinantly
expressed leukemia inhibitory factor (LIF). To exit from
pluripotency and induce differentiation, LIF was with-
drawn and retinoic acid (RA, Sigma, R2625) was added to
the medium to a final concentration of 1 M. For all ex-
periments, 4 h prior to harvest, cell culture medium was re-
moved, cells washed twice with PBS and fresh medium con-
taining either LIF or RA was added.
FAIRE-STARR-seq
As input material for the reporter screen, accessible chro-
matin from E14 mESCs treated with RA (Sigma, #R2625)
for 4 h was isolated by formaldehyde-assisted isolation of
regulatory elements (FAIRE, (46)) and subsequently cloned
into the STARR-seq screening vector (Addgene #71509)
following the protocol described in Arnold et al. (38).
The details of our library preparation are provided in the
supplementary information.
STARR-qPCR
Putative enhancer sequences (Supplementary Table S1)
were amplified by nested PCR from genomic DNA derived
from E14 cells using standard PCR procedures. Primers
(Supplementary Table S1) were designed to generate the
same overhangs as used for Illumina sequencing. The neg-
ative (nc1 and nc2, GR responsive elements) and posi-
tive (CMV enhancer) control regions as well as RAR
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motif variants were ordered as gBlocks (IDT) and are
listed in Supplementary Table S1. DNA fragments were
subsequently cloned into the STARR-seq screening vec-
tor (pSTARR-seq human, Addgene plasmid #71509) using
the In-Fusion® HD Cloning Kit (Takara/Clonetech). For
transfection of reporter plasmids, E14 mouse ESCs were
plated at a density of 1.4 × 104 cells/cm2 of a 24-well plate
with ES medium supplemented with 17% FBS and LIF. The
next day, cells were washed with PBS and fresh medium was
added. Subsequently, cells were transfected with individual
reporter plasmid using Lipofectamin 2000 (Invitrogen) ac-
cording to the manufacturer’s instructions. Twenty hours
after transfection, cells were washed twice with PBS and
fresh ES medium, containing LIF, 1 M RA or no addi-
tional reagent, was added. After another 4 h of incuba-
tion, cells were harvested, RNA extracted (RNeasy Mini
Kit, Qiagen), followed by cDNA synthesis (PrimeScript
RT Reagent Kit, Takara, using oligodT and random hex-
amer primers). Reporter transcript levels were quantified
by qPCR with primers specific for GFP and normalized to
the expression of two housekeeping genes (Rpl19 and Actb).
Primers are listed in Supplementary Table S1.
ATAC-, ChIP- and RNA-seq experiments
ATAC-, HM ChIP- and RNA-seq experiments from our
laboratory have been published previously (23). RAR
ChIP was performed for this study. In short:
ATAC-seq. 75 000 low passage (<10) E14 cells were cul-
tivated for 48 h in ES medium prior to subjecting them
to an improved ATAC-seq protocol as described in Corces
et al. (47). The resulting transposase-fragmented and PCR-
amplified DNA was cleaned up using AMPure XP beads
(Agencourt). High-throughput sequencing was performed
generating ∼50 million 50 bp paired-end reads per sample
using the HiSeq 4000 (Illumina) device.
ChIP-seq. HM ChIP experiments were performed essen-
tially as described in the standard BLUEPRINT protocol
(www.blueprint-epigenome.eu, details in supplementary in-
formation), while the RAR ChIP was performed as de-
scribed elsewhere (48), with small modifications. A more de-
tailed description can be found in the supplementary infor-
mation.
RNA-seq. 2 × 105 low passage (< 10) E14 cells were plated
per 10 cm dish and cultivated for 48 h in regular ES medium.
Next, medium was exchanged for fresh ES medium con-
taining either LIF or 1 M retinoic acid (Sigma, R2625).
After 4 h, cells were harvested and RNA extracted using
the RNeasy Mini Kit (Qiagen) according to the manufac-
turer’s instructions. The experiment was performed in bi-
ological triplicates. Sequencing libraries were generated us-
ing the TruSeq® Stranded mRNA Kit (Illumina) and high-
throughput sequencing was performed on a HiSeq 2500 (Il-
lumina) device generating approx. 100 million 50 bp paired-
end reads per sample.
Generation of clonal cell lines with CRISPR/Cas9-mediated
genomic deletions and mutations
sgRNAs targeting regions of interest were designed us-
ing the CRISPOR tool (http://crispor.org/, 49), ordered as
complementary DNA oligonucleotides (Sigma) with over-
hangs for BbsI, and cloned into the pSpCas9(BB)-2A-Puro
(PX459) V2.0 plasmid (Addgene plasmid #62988) as de-
scribed in Ran et al. (50). All sgRNA sequences are listed
in Supplementary Table S1. To delete regions of interest,
two million E14 cells were transfected with a pair of sgRNA
plasmids (as indicated), 1 g per plasmid, using a Nucle-
ofector™ 2b device and the Mouse ES Cell Nucleofector
Kit (Lonza, VAPH-1001) according to the manufacturer’s
instructions and plated into two 10 cm dishes. Twenty-
four hours after transfection, medium was exchanged for
fresh ES medium, and after another 24 h the medium
was exchanged for fresh ES medium containing 2.5 g/ml
Puromycin. The next day, medium was exchanged again for
ES medium without selection. Subsequently, medium was
exchanged every 2 days until round colonies formed (7–10
days post transfection). Colonies were picked by pipetting
and individually transferred into 48-well plates. E14 clonal
lines were expanded, genomic DNA was extracted (QI-
Aamp DNA Mini Kit, Qiagen) and lines were genotyped
using primers listed in Supplementary Table S1 and Phusion
High-Fidelity PCR Master Mix (with GC Buffer) (Thermo
Scientific, F532). PCR products of candidate clonal lines
showing predicted PCR band sizes in agarose gel elec-
trophoresis, were send for validation by sanger sequenc-
ing (Eurofins). To probe for biallelic alterations, PCR prod-
ucts were cloned into the Zero Blunt™ vector (PCR Cloning
Kit, Thermo, K270020), transformed into Escherichia coli,
four to eight individual bacterial colonies were picked, plas-
mid DNA isolated (QIAprep Spin Miniprep Kit, Qiagen)
and send for Sanger sequencing. Genomic deletions and
mutations of E14 clonal lines are listed in Supplementary
Table S3.
RT-qPCR
RNA from E14 or clonal cell lines, treated as indicated, was
extracted using the RNeasy Mini Kit (Qiagen) according
to the manufacturer’s instructions including a DNase treat-
ment. 1 g total RNA was subjected to cDNA synthesis ap-
plying the ProtoScript® First Strand cDNA Synthesis Kit
(NEB, E6300S) with the included Oligo d(T)23 VN primer
according to the manufacturer’s instructions. cDNA was di-
luted 1:12.5–1:20 prior to qPCR which was performed as
described in Thormann et al. (51). Transcript levels were
normalized to the expression of housekeeping genes (Rpl19
and Actb). Genes quantified to asses the interferon response
were Ifna4, Ifnb1, Ifti1 and Isg15. Primers are listed in Sup-
plementary Table S1.
NGS data analyses
All NGS data analyses are described in the supplementary
information.
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RESULTS
Generation of a quantitative enhancer-activity map of the
mESC genome
To assess the enhancer activity of putative regulatory re-
gions in mESCs, we performed a massively parallel en-
hancer reporter assay. To limit the complexity of the library,
we prioritized regions that are likely to act as enhancers (52)
by focusing on accessible chromatin isolated by FAIRE as
input material for our STARR-seq (self-transcribing active
regulatory regions) (38) library (Figure 1A–C). Although
this idea was new at the time of conception, a similar ap-
proach has by now also been described by others that iso-
lated putative regulatory elements by either FAIRE (44) or
ATAC (43).
To get quantitative information regarding enhancer ac-
tivity, we developed a modified version of the STARR-
seq assay, which introduces unique molecular identifiers
(UMIs) during the reverse transcription step (Figure 1A,
Supplementary Figure S1A). A similar approach has been
described, however in that case UMIs are introduced in a
first PCR cycle after the reverse transcription step (53). The
introduction of UMIs allows one to distinguish between
independent transcript replicates and PCR duplicates that
can dramatically distort the relative quantities of individ-
ual fragments within a library (54). Genome-wide corre-
lation analyses of read distributions of individual FAIRE-
STARR-seq samples revealed that outlier regions with ex-
tremely high read coverage in only one replicate were effi-
ciently removed during the UMI filtering step (Supplemen-
tary Figure S1D) indicating that such regions are PCR am-
plification artefacts.
Next, active FAIRE-STARR enhancers were identified
by performing peak calling for significantly enriched re-
gions using the input library as background. This was
done for each of the three biological replicates individually
and for the merged replicates. We focused only on high-
confidence regions by filtering for enhancers which were
called in at least two replicates and were captured by at least
three different fragments. Using these criteria, we identified
4765 active enhancers with assigned quantitative STARR-
scores, while the majority of the input regions showed no
enhancer activity (Figure 1D, E, and Supplementary Fig-
ure S1H). To determine what distinguishes active enhancers
from their inactive counterparts (182 194 accessible regions
without STARR activity covered by our library), we an-
alyzed sequence composition, TF occupancy and enrich-
ment of a panel of histone modifications (HMs) linked
to enhancers in mESCs (2,55). In order to reduce the re-
dundancy inherent in many motif databases that contain
multiple highly similar motifs for related TFs, we used the
JASPAR 2018 clustered vertebrate motif matrices which
group related motifs into non-redundant clusters (56,57,
Supplementary Table S4). As expected, we found that ac-
tive enhancers are enriched for sequence motifs of pluripo-
tency TFs such as POU5F1::SOX2 (cluster 18), SOX2 (clus-
ter 33), MYC (cluster 4) and STAT3 (cluster 32) (Figure
1G). Furthermore, CG-rich motif clusters (28: SP/KLF, 54:
ZNF263 and 72: NRF1) were enriched for these regions.
We also compared the quantity of enriched motifs between
active and inactive regions and found that the number of
significant motif hits is higher for active enhancers when
compared to their inactive counterparts (Figure 1G). On
the other hand, inactive regions are characterized by an
enrichment for motif clusters NEUROD2 (cluster 8) and
RUNX3 (cluster 38), which contain TFs associated with dif-
ferentiation and cell-type specific TFs, most of which are
not expressed in mESCs (Supplementary Figure S1G) sug-
gesting that these regions might be primed for activation
when ESCs differentiate towards different cell types. Inter-
estingly, the motif for CTCF, a master regulator of the ge-
nomic architecture (58), is enriched for both groups, but
this enrichment is more pronounced for inactive regions
(Figure 1G). Consistent with the observed motif enrich-
ments, we found that ChIP-seq data for a panel of TFs in-
volved in pluripotency showed higher levels of genomic oc-
cupancy at active enhancers than at their inactive counter-
parts whereas CTCF occupancy was slightly higher for in-
active regions (Figure 1H). To compare the chromatin land-
scape at the endogenous genomic loci between active en-
hancers and inactive regions, we performed ChIP-seq for
eight HMs in mESCs. Intersection of the HM data showed
that all three investigated HMs associated with active en-
hancers, H3K4me1, H3K27ac, and H3K122ac, as well as
the promoter mark H3K4me3 are highly enriched at active-
compared to inactive input regions. For HMs associated
with transcription, H3K36me3 and H3K79me2, we also
find an enrichment however not directly at the active en-
hancer but rather in the regions flanking it (Figure 1H). In
contrast, repressive marks H3K27me3 and H3K9me3 are
depleted at active regions when compared to inactive input
regions. Consistent with elevated H3K4me3 levels, we found
that almost half of the active FAIRE-STARR enhancers are
promoter-proximal regions. This percentage is much higher
than in our library for which less than 10% of the regions
map near promoters (Figure 1F). These findings are con-
sistent with a published study showing that promoters can
act as enhancers that control the expression of other genes
(6). Taken together, we established a quantitative approach
to determine the enhancer activity of accessible genomic re-
gions resulting in a genome-wide catalog of putative regula-
tory regions in mESCs. The enhancer activity map we gen-
erated can serve as a resource and several examples of how
it can be used and intersected with other types of data to
study various aspects related to enhancer activity and gene
regulation in mESCs can be found in the next paragraphs.
Quantitative FAIRE-STARR-seq identifies transcription
factors associated with distinct enhancer activity levels
In addition to identifying which regions are active, the
UMIs added during the reverse transcription step facilitate
a quantitative assessment of enhancer activity based on the
FAIRE-STARR data. This allowed us to rank the identi-
fied active FAIRE-STARR regions by their activity and,
for example, to screen for features associated with differ-
ent activity levels. To determine if enhancer activity corre-
lates with expression of nearby genes, we first grouped the
active regions into five consecutive quantiles of ascending
activity (Figure 2A). Next, for each group the individual
regions were associated to neighboring genes by distance.
Using this approach, we found that the expression levels for
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Figure 1. FAIRE-STARR-seq in mouse embryonic stem cells. (A) Schematic representing the workflow of FAIRE-STARR-seq. (B) Heatmaps depicting
normalized read distribution of the FAIRE-STARR input library, DNase- and ATAC-seq at the FAIRE-STARR input regions. (C) Correlation analysis
of genome-wide read distribution, comparing the input library with DNase-seq data (ENCODE). Normalized and log1p transformed reads per 10 kb
genomic bin are shown. (D) Heatmap showing normalized FAIRE-STARR-seq signal at active (4765) or inactive (182 194) input regions. (E) Exemplary
genomic region encompassing the Pou5f1 gene. The FAIRE-STARR-seq signal merged from three replicates (normalized to input) is shown and the three
active (weakly and highly active) regions detected in the depicted region, as well as one exemplary inactive region covered by our library, are highlighted. In
addition, ChIP-seq data of histone modifications (HMs) as indicated, RNA-seq, ATAC-seq and input library signal from mESCs are shown. (F) Genomic
distribution of input regions and FAIRE-STARR enhancers with respect to annotated Refseq genes. Promoters were defined as the regions 1 kb upstream
of a TSS. (G) Motif enrichment analysis comparing the 4765 FAIRE-STARR active and an equal number of randomly sampled inactive input regions
(mean E-values of ten subsamplings from inactive regions). Enrichment of motif clusters is indicated as −log10E-value and the -log ratio comparing active
versus inactive enrichment is shown. Enriched motifs (E ≤ 1e−3) with a minimum 15-fold −log difference of E-values between the two groups are shown.
The JASPAR 2018 vertebrate clustered motif database was used as reference and listed TF names display TF groups clustered by consensus motif similarity
(57). (H) Anchorplots showing mean normalized ChIP-seq enrichment of the indicated HMs or TFs at FAIRE-STARR active or inactive input regions.
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Figure 2. FAIRE-STARR-seq enables quantification of enhancer activity and activity level-associated sequence features. (A) FAIRE-STARR enhancers
were ranked for their activity (log STARR score) and divided into five groups of ascending enhancer activity (highlighted by increasing background
coloring). Dashed lines depict the 10th and 90th percentiles of STARR activity. (B) Expression of genes paired with FAIRE-STARR enhancers, for each
of the five activity groups as depicted in (A). Genes were paired with FAIRE-STARR enhancers by distance using GREAT (84) and TPM values of
RNA-seq data are shown. Boxplots depict the distribution of expression of all genes per group, whiskers extend to 1.5 IQR. TPM values of individual
genes are shown as dots. P-values for unpaired Wilcoxon tests comparing neighboring groups are indicated. (C) TF sequence motifs enriched at active
FAIRE-STARR enhancers, comparing the most active 10% (high) and least active 10% (low) of the active enhancers. Enriched motifs (E ≤ 1e−3) with a
minimum 1-fold -log enrichment ratio between the two groups are shown. The JASPAR 2018 vertebrate clustered motif database was used as reference and
a representative TF for each cluster is listed (57). Boxplots depicting (D) the number of significantly enriched motifs and (E) length of low- or high-ranking
enhancers. Means are indicated as well as P-values for unpaired Wilcoxon tests comparing the two groups.
the genes of each category correlate with the enhancer ac-
tivity scores with significant differences between the neigh-
boring groups (Figure 2B). These findings suggest that our
quantitative FAIRE-STARR scores recapitulate the activ-
ity of enhancers in their endogenous genomic setting where
they influence the expression level of nearby genes. Simi-
larly, H3K27ac levels, a mark that is used as a proxy for en-
hancer activity (59), correlate positively with our STARR
score (Supplementary Figure S2A and B). This further in-
dicates that our STARR activity scores capture the activity
of enhancers in their endogenous genomic setting.
To investigate the role of DNA sequence in directing dif-
ferent levels of enhancer activity, we performed TF motif
enrichment analysis comparing active enhancers that are
ranked either at the top or bottom ten percent by STARR
activity score (‘high’ and ‘low’, Figure 2C). Interestingly, we
found that the motifs for pluripotency TFs OCT4, SOX2
and NANOG (cluster 18) are enriched for high- as well as
low-ranking enhancers indicating that high activity levels
are not dictated by the presence of sequence motifs for these
TFs. Rather, the top-ranking enhancers are characterized
by motifs of the SP/KLF (cluster 28) and ETS (cluster 7)
TF families. These factors are ubiquitously enriched at pro-
moters, irrespective of the cell type and are accompanied
by motifs for cell-type specific TFs (60). For the low-activity
enhancers, we found enrichment of motifs of cell type defin-
ing TFs, such as MYOG (cluster 9) and POUF4 TFs (clus-
ter 30), suggesting a priming of enhancers that might play a
role in later developmental stages when these TFs become
expressed. Low activity enhancers were also enriched for the
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motif of p53, which was recently found to bind ‘dormant’
enhancers in mESCs that are located in inaccessible chro-
matin and become activated upon cellular stress or during
reprogramming (45). Another plausible explanation for in-
creased activity levels of enhancers could be the absolute
number of motifs per enhancer as well as on the diversity
of these motifs (61). Accordingly, we found that the high-
activity enhancers, on average, contain more motifs (10.6
compared to 9.8 average motifs/enhancer, Figure 2D) and
were 14% larger than enhancers with low activity (385 bp
versus 338 bp for low-activity enhancers, Figure 2E). To-
gether, these findings indicate, that the nature of the se-
quence motifs present as well as the absolute number of mo-
tifs are critical drivers of enhancer activity.
Epigenetic features and transcription factor occupancy define
distinct enhancer subsets
Enhancers can be predicted based on the patterns of HMs
present, with active enhancers harboring a high H3K4me1
to H3K4me3 ratio as well as high H3K27ac levels at flank-
ing nucleosomes (2,23,55). However, alternative histone
marks for active enhancers have been described (62–64).
Moreover, although HMs correlate with enhancer activ-
ity it is largely unclear if this reflects a causative link (re-
viewed in 65). To gain insight into the epigenetic landscape
present at the active STARR enhancers, we clustered the
active enhancers based on ChIP-seq signal for a panel of
eight different HMs (Figure 3A). Consistent with our find-
ing that active enhancers are enriched in promoter regions
(Figure 1F), we found that about half of the active FAIRE-
STARR enhancers show HMs characteristic for active pro-
moters (cluster A: high H3K4me3, low H3K4me1, and high
H3K27ac signal). An overlay with annotated promoter re-
gions confirmed that the enhancers of cluster A (from here
onwards, we will refer to these as ‘enhancer-promoters’ or
in short ‘E-promoters’) map to annotated promoters (Fig-
ure 3A). Moreover, RNA-seq as well as H3K36me3 and
H3K79me2 levels show that the genes at these promoters
are actively transcribed in mECSs. Notably, enhancers of
this cluster do not display the classical enhancer signature of
high H3K4me1 over H3K4me3 levels, and consequently are
not recognized by the CRUP enhancer prediction tool (23),
which like many prediction tools prioritizes high H3K4me1
over H3K4me3 levels to call enhancers. This is different for
enhancer clusters B to E which display high H3K4me1 lev-
els and varying levels of H3K27ac, thus displaying a typ-
ical epigenetic signature of active enhancers and accord-
ingly a larger overlap with enhancers predicted by CRUP.
Clusters B and C, which display higher H3K27ac signals
than clusters D and E, are highly active enhancers, show-
ing high STARR activity as well as higher CRUP predic-
tion scores. Cluster F, on the other hand, displays a typi-
cal H3K4 methylation pattern of enhancers but is lacking
high H3K27ac levels, indicative of enhancers poised for ac-
tivity (55,66). Accordingly, these enhancers have quite low
enhancer prediction scores, but still can be identified as ac-
tive in our FAIRE-STARR-seq assay. This indicates, that
FAIRE-STARR-seq is able to pick up enhancers with a
poised HM signature, while CRUP discards those regions
by design.
Cluster G, shows a rather uncommon HM pattern of
enriched H3K36me3, a mark for active transcription, to-
gether with elevated H3K9me3, a hallmark of heterochro-
matin. The combination of these two marks has previously
been reported to occur at the same nucleosome to mark
lowly expressed genes and weak enhancers (67). Interest-
ingly, alignment with the RepeatMasker database (68) re-
vealed that 93% of cluster G enhancers map to repeat ele-
ments. The majority of these repeats are from the endoge-
nous retrovirus-K (ERVK) family (Supplementary Figure
S3F), a rather young family of mouse-specific endogenous
retroviruses, which can act as enhancers in mESCs (28). Fi-
nally, cluster H, which exhibits the lowest STARR signal,
also shows the lowest accessibility based on our ATAC-seq
data and lowest enrichment of each HM except H3K9me3.
This indicates that these regions are not very accessible, nor
active, in the endogenous genomic setting and may only be
able to unleash their activity in the episomal STARR-seq
setting where such sequences are taken out of their repres-
sive endogenous chromatin context.
Motivated by a study claiming that H3K122ac marks
a unique class of active enhancers lacking H3K27ac (62),
we included this mark in our ChIP-seq experiments. How-
ever, contrary to the published study, we did not observe a
convincing cluster with H3K122ac but lacking H3K27ac.
Rather, we found that, in general, the signal for H3K27ac
and H3K122ac is essentially the same at enhancers. This
is different for promoters, where we found H3K122ac en-
riched at H3K4me3-marked gene promoters, irrespective of
the H3K27ac state (Supplementary Figure S3H).
To study the link between enhancer clusters and nearby
gene expression and to test if they are associated with dif-
ferent categories of genes, we paired the clustered enhancers
with genes by distance and analyzed gene expression levels
(Figure 3B) as well as gene ontologies (Figure 3C). Overall,
we found that the expression of enhancer cluster-associated
genes correlates well with epigenetic signatures of individual
clusters. For example, we find the highest mean expression
level for genes associated with clusters B and C, that show
the most prominent signatures of active enhancers (Figure
3B). In contrast, we find the lowest expression levels for
genes associated with clusters G and H, two enhancer clus-
ters with low levels of active enhancer marks. Interestingly,
the function of the genes associated with different clusters
also diverges. For instance, E-promoter cluster A-associated
genes are involved in more general cellular processes, such
as nucleic acid, nitrogen compound, and organic substance
metabolic processes, whereas genes associated with clus-
ters B and C play a role in early embryonic stages (Figure
3C). Enhancer clusters D to F are associated with genes of
medium expression levels, which are enriched for genes typ-
ically expressed at later time points during embryonal de-
velopment. Cluster G enhancers correspond to genes with
rather low expression levels which are enriched for zinc fin-
ger and KRAB-domain containing genes. The genes of this
family of TFs have been described as marked by H3K36me3
and H3K9me3 (69), the combination we now identify at the
cluster of associated enhancers as well. Finally, enhancer
cluster H is associated with genes with the lowest mean
expression levels of all investigated clusters and no signifi-
cantly enriched GO terms could be identified. This is in line
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Figure 3. Functional mESC enhancers reside in different epigenomic environments. (A) FAIRE-STARR enhancers were clustered (k-means clustering)
based on the enrichment of the eight investigated histone modifications. For each cluster, the STARR-, ATAC- and RNA-seq signals were plotted as were
promoter regions (Prom) defined as 1 kb up- and downstream of the TSSs of annotated Refseq genes. Enhancer probability scores predicted by CRUP
from mESC data are also shown. (B) Genes were assigned to enhancer clusters using GREAT and RNA-seq expression data is shown as dots for individual
genes (TPM normalized) and as boxplots for each enhancer cluster. (C) Gene ontology analysis of genes associated with each enhancer cluster showing the
fifteen most significant GO terms per cluster and their false discovery rate (-log10BionomFdrQ, cutoff 1e−03). For each ontology, the number of observed
genes (ObsGenes), the significance, and the source of the assigned ontology are shown. (D) TF motif enrichment analysis (AME) for each enhancer cluster
using the JASPAR 2018 vertebrate clustered motif matrices. TF motifs which were enriched (E ≤ 1e−5) for at least one cluster were clustered for TF
occurrences applying wards clustering and Manhattan similarity measures. (E) Venn diagram showing the intersection of FAIRE-STARR and CRUP
enhancers. FAIRE-STARR enhancers which overlap with CRUP enhancers (pos) or do not overlap (neg) were assigned to the HM clusters defined in (A).
with our hypothesis that these enhancers are a heterogenous
group, which are repressed in mESCs but can be activated
at different points during differentiation.
Next, we compared the sequence composition of the en-
hancer clusters, and found that they display characteristic
patterns of motif enrichment (Figure 3D). One example is
the E-promoter cluster A, which is enriched for many mo-
tifs including CG-rich motifs like SP/KLF family (cluster
28) and NRF1 (cluster 72), as well as motifs of the ETS
family (cluster 7). Similarly, analysis of published TF ChIP-
seq data showed different binding patterns for individual
enhancer clusters (Supplementary Figure S3A). Consistent
with a selective enrichment of their motifs at E-promoters,
we found that c-MYC and Ronin preferentially occupy en-
hancers of E-promoter cluster A (Supplementary Figure
S3A). The situation is different for KLF4 (a member of
the SP/KLF family) which, as expected, binds E-promoter
cluster A, but also to other enhancer clusters that are en-
riched for the SP/KLF motif (Supplementary Figure S3A).
Of note, apart from the transcriptionally active E-
promoters, we also find many actively transcribed promot-
ers without FAIRE-STARR-seq activity (Supplementary
Figure S3B) showing that enhancer activity is not a gen-
eral feature associated with active promoters. Comparison
of these promoters with E-promoters shows stronger en-
richment of c-MYC and RONIN at E-promoters, but simi-
lar KLF4 occupancy at both groups (Supplementary Figure
S3C and D). Further, motif enrichment analysis comparing
E-promoters and promoters lacking STARR-seq activity
revealed differences in sequence composition (Supplemen-
tary Figure S3E). For example, consistent with the observed
selective enrichment by ChIP, the motif for MYC (cluster
4) was more highly enriched for E-promoters than for regu-
lar promoters, while motifs for pluripotency factors OCT4,
SOX2, and NANOG (cluster 18) were more enriched at reg-
ular promoters that at E-promoters.
A global comparison between enhancers predicted based
on chromatin features using CRUP and active enhancers
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identified by FAIRE-STARR revealed that only 2,437
(52.1%) of the active STARR enhancers were also predicted
by CRUP (Figure 3E) while CRUP predicted 22,833 regions
that were not identified by FAIRE-STARR. The majority
of FAIRE-STARR enhancers which were not predicted by
CRUP fall into cluster A, the E-promoters, and thus dis-
play a chromatin signature which is filtered-out by CRUP.
The second largest group of STARR enhancers not detected
by CRUP are cluster H regions, repressed enhancers, which
are not marked by the classical enhancer signature recog-
nized by CRUP. On the other hand, enhancers which were
only predicted by CRUP but not picked-up by FAIRE-
STARR-seq showed very low chromatin accessibility by
ATAC, and overall lower activation marks (Supplementary
Figure S3G). This indicates, that these regions were not in-
cluded in the FAIRE-STARR input library and thus could
not be identified as active. Additionally, it is possible that a
subset of the enhancers predicted only by CRUP and not by
FAIRE-STARR are not active.
Together, we find that enhancers can be grouped based
on different HM patterns. These enhancer clusters have dif-
ferent activities and are associated with genes with different
functions. The partial overlap with CRUP enhancer predic-
tions highlights that HM-based enhancer predictions and
functional assays such as FAIRE-STARR-seq can provide
complementary information. Additionally, our data is in
line with other studies suggesting that a formal distinction
between promoters and enhancers, and the exclusion of pro-
moter signatures from HM-based predictions, might not
make sense given that promoters can exert both functions
(6,8,70).
Sequence-based prediction of active enhancers in mESC
As shown above, enhancer prediction based on HMs of-
ten excludes E-promoters and depends on several ChIP-
seq data sets which are not always available. Here, we set
out to build an enhancer prediction model solely based on
DNA sequence using their activity scores from FAIRE-
STARR-seq to predict if a given DNA sequence shows en-
hancer activity in mESCs or not. Given the different se-
quence composition and accordingly motif enrichment of
promoter and enhancer regions (Figure 3D), we decided to
build two distinct classifiers: one for ‘traditional’ enhancers
and one for E-promoters. Specifically, we took all accessi-
ble regions from our input library and divided them into
two groups: Those overlapping with annotated promoters
and those that do not overlap. Next, within each group, we
ranked the regions by their STARR-score and used the 1%
(enhancers, Figure 4A–C, 1% of 170 190 putative enhancer
regions: 1702 regions) or 10% (E-promoters, Supplemen-
tary Figure S4A, 10% of the 16 769 input regions overlap-
ping with promoters: 1677) of regions with the highest or
the lowest STARR-score to train two regularized logistic
regression (elastic net) models to classify active and inac-
tive DNA sequences. To this end, a nested cross-validation
approach was performed, where 75% of regions were used
as the training data to optimize the model, while the re-
maining regions were used to assess the predictive perfor-
mance on unseen data (Figure 4C). As features for each
model, we used the width of the region and enrichment of
clustered JASPAR motif matrices (56). Each elastic net re-
gression classifier was fitted to maximize the cross-validated
mean AUC which yielded 0.75 for enhancer regions (Figure
4D) and 0.87 for E-promoters (Supplementary Figure S4B).
Thus, the classifier for both enhancers and E-promoters per-
formed quite well, suggesting that enrichment patterns of
TF motifs alone can be used to distinguish between active
and inactive regions for both promoter and enhancer re-
gions with reasonable accuracy.
To determine which features were most important in pre-
dicting if a region is active, we analyzed the ranked model
coefficients (Figure 4E and Supplementary Figure S4C)
which reflect the importance of individual features for each
optimized activity-prediction model. Interestingly, the two
features with the highest coefficient for both the E-promoter
and the enhancer-prediction model are enhancer width and
the motif for ETS TFs (cluster 7). For classification of en-
hancers, the motif for pluripotency TFs SOX2, OCT4 and
NANOG (cluster 18) was among the top features associ-
ated with active regions (Figure 4E), while it showed a nega-
tive coefficient in the E-promoter classification (Supplemen-
tary Figure S4C), indicating that pluripotency factors con-
tribute to enhancer but not E-promoter activity. Similarly,
the motif for CTCF scored a positive coefficient for the E-
promoter classification (Supplementary Figure S4C), while
it was slightly negative for active enhancers (not in figure,
coeff. = −0.045).
Together, our modeling demonstrates that the activity
state of a sequence (active versus inactive) can be predicted
from DNA sequence for both enhancers and E-promoters
using a rather small feature set of 79 clustered TF motifs
and enhancer width as input.
FAIRE-STARR-seq identifies enhancers that change their
activity upon exiting pluripotency
Next we set out to make use of the quantitative nature
of our assay, by investigating the changes of enhancer ac-
tivity following differentiation. To identify enhancers that
change their activity upon exiting pluripotency, we ana-
lyzed enhancer activity during the early stages of differ-
entiation using the FAIRE-STARR-seq approach. Specif-
ically, we compared cells treated with LIF to maintain
pluripotency with cells from the same transfection-batch
that were treated for 4 hours with retinoic acid (RA) to ini-
tiate differentiation towards the neuronal lineage (Figure
5A) (34). We then focused on enhancer regions which ei-
ther lost (LIF-dependent) or gained (RA-inducible) activ-
ity upon differentiation. This resulted in the identification
of 616 LIF-dependent and 386 RA-inducible enhancers,
which show varying degrees of loss or gain of STARR ac-
tivity (Figure 5B and Supplementary Figure S5D). The ac-
tivity of these enhancers correlated with changes in the ex-
pression of nearby genes, with genes near RA-inducible
enhancers showing, on average, an increase in gene ex-
pression (and more associated upregulated than down-
regulated genes) whereas the expression genes near LIF-
dependent enhancers showed, on average, a slight decrease
in expression upon differentiation (and more repressed than
upregulated genes, Figure 5C and Supplementary Figure
S5B, C). Notably, when compared to all active mESC en-
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Figure 4. Sequence-based prediction of active enhancers. (A) The regions of the FAIRE-STARR library were first divided by their overlap with ENSEMBL
promoters (region up to 500 bp upstream of a TSS). Regions which overlap with promoters were used to generate an E-promoter prediction model, whereas
those not overlapping were used for the enhancer prediction model. To this end both groups (B) putative enhancers and S4A) promoters) were ranked for
their STARR score, and 1 or 10% highest or lowest ranking regions were used for model generation. (C) Cartoon depicting how the enhancer prediction
model was trained on ranked regions from our FAIRE-STARR-seq analysis using enrichment of JASPAR 2018 vertebrate clustered motif matrices and
region width as independent variables. 75% of the highest and lowest ranking regions were used for model training, while the remaining 25% were used for
testing. (D) Plot shows model performance as receiver operating characteristic (ROC) curve for each of the outer cross-validation folds, mean ROC curve
with area under the curve (AUC) and its standard deviation. (E) The 30 most predictive variables for the optimal enhancer prediction model and their
coefficients are shown. Positive coefficients indicate a positive association with high STARR scores, while motifs with negative coefficients are associated
with low-scoring elements.
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Figure 5. Differentiation-associated changes in enhancer activity. (A) Treatment scheme to investigate how inducing differentiation of mESCs changes
enhancer activity. (B) Mean FAIRE-STARR signal (top) and heat-maps (bottom) for LIF-dependent and RA-inducible STARR enhancers. (C) Number
of differentially expressed genes (|log2FC| ≥ 1, Padj ≤ 0.05) paired with enhancers by distance using GREAT. (D) Differentially enriched TF motif clusters
(JASPAR 2018 vertebrate clustered matrices) for RA-induced and LIF-dependent enhancers were identified using AME (E ≤ 1e−3, −logRatio ≥ 5).
(E) Candidate FAIRE-STARR enhancers were cloned individually and assessed for enhancer activity by RT-qPCR targeting GFP reporter transcripts
(normalized to Rpl19 and Actb). 20 h after transfection, E14 mESCs were treated for 4 h either with LIF, RA or ES medium only (none). Bar plots show
normalized mean expression ± SE of three replicates (dots). (F) TF motif-matches identified by JASPAR scan (Supplementary Table S1) for enhancers as
indicated were deleted by site-directed mutagenesis and activity was analyzed as described in (E). (G and H) Genomic loci encompassing STARR enhancers
selected for genomic deletion using CRISPR/Cas9. Normalized FAIRE-STARR-input, -seq, and RNA-seq signals are shown. RefSeq genes are shown in
either black (protein coding genes) or red (non-coding genes). (I and J) Expression of genes (RT-qPCR) near the deleted enhancer and of control genes
for clonal wild type (wt) and enhancer heterozygous (E+/−) and homozygous (E−/−) deletion clones. Bar plots represent mean gene expression ± SE
of three biological replicates (dots) and 1–3 clonal cell lines (number indicated in brackets) after 4 h of LIF or RA treatment. Data points for individual
clonal lines are shown as dots with matching shapes.
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hancers (Figure 1F) that are typically promoter-proximal,
the differentially active enhancers are most frequently found
at distal intergenic regions (Supplementary Figure S5A)
and display distinct TF motif enrichments (Figure 5D).
For instance, RA-inducible enhancers are more enriched
for RAR::RXR and ETS-family motifs than the LIF-
dependent enhancers consistent with the activation of RAR
upon treatment of cells with its cognate ligand. Accord-
ingly, when we performed ChIP-seq targeting RAR from
RA-treated cells, we found that RAR is enriched at RA-
inducible enhancers whereas no such enrichment was found
for the LIF-dependent enhancer regions (Supplementary
Figure S5E). Similarly, consistent with STAT3 activation by
LIF, STAT3 binding is more enriched at the LIF-inducible
enhancers than at RA-inducible enhancers (Supplemen-
tary Figure S5E). Moreover, LIF-dependent enhancers are
more enriched for OCT4:SOX2, SP1-like family, SOX2,
NFY, TEAD and NRF1 motifs than the RA-inducible en-
hancers. The enrichment of these sequence motifs is re-
flected in enriched binding of OCT4, SOX2, NANOG and
KLF4 based on published ChIP-seq data (Chen et al.
(71), Supplementary Figure S5E). Interestingly, binding of
OCT4, SOX2 and NANOG was not only enriched at LIF-
dependent but also at RA-inducible enhancers when com-
pared to all active mESC enhancers. This indicates that
pluripotency TFs play a supportive role at RA-inducible en-
hancers during the early stages of differentiation.
Next, the regulatory behavior of several LIF-dependent
and RA-inducible enhancers identified in our screen was
tested by cloning individual active regions into the STARR-
seq vector and analyzing their activity by qPCR (Figure
5E). One exemplary LIF-dependent enhancer we tested
is located distal to the Socs3 (suppressor of cytokine
signaling-3) gene, which is activated by LIF-mediated
STAT3 signaling (72). We confirmed that the Socs3 en-
hancer is LIF-inducible and this induction is blunted when
the two identified STAT3 motifs were mutated (Figure 5F).
Furthermore, mutation of the two SOX2 motifs of the
Socs3 enhancer leads to a marked loss of basal activity. Fi-
nally, the combined mutation of all SOX2 and STAT3 mo-
tifs abolished enhancer activity completely. This finding il-
lustrates the importance of these TFs in facilitating LIF-
dependent activity as suggested by the enrichment of se-
quence motifs for these TFs at LIF-dependent enhancers
(Figure 5D). We also characterized an RA-inducible en-
hancer upstream of the RA target gene Cyp26a1, which
is pivotal for proper differentiation (73). The Cyp26a1 en-
hancer is inactive during pluripotency but is massively up-
regulated upon differentiation (Figure 5E and F). Consis-
tent with a role of RAR in activating this enhancer, muta-
tion of both of the identified RAR::RXR motifs resulted
in a complete loss of induction upon RA treatment (Fig-
ure 5F). As a final enhancer, we analyzed the RA-inducible
Hoxa enhancer (Figure 5E and F), which is located over
70 kb upstream of the RA-responsive Hoxa gene cluster
(74). The Hoxa enhancer shows basal activity in pluripo-
tency which increases upon differentiation (Figure 5F). In-
terestingly, mutation of the two identified RAR::RXR
motifs reduced basal activity during pluripotency but did
not impair the RA-induced activation, suggesting that other
motifs mediate the activation. As expected, mutation of the
only identified OCT4:SOX2 motif of the Hoxa enhancer re-
duced activity in pluripotency whereas the combined mu-
tation of both RAR::RXR and the OCT4:SOX2 motifs
completely abolished basal as well as RA-induced activa-
tion of the Hoxa enhancer.
To test the role of two RA-inducible enhancers in the reg-
ulation of nearby genes in the endogenous genomic context,
we generated CRISPR/Cas9-mediated genomic deletions
of these enhancers in mESCs. The first enhancer we targeted
was the Cyp26a1 enhancer (E) described above (Figure 5G).
We were able to generate a single homo- and three heterozy-
gous clonal lines for the Cyp26a1 E deletion (Supplemen-
tary Figure S5F). Analysis of the clonal lines revealed that
heterozygous deletion of the Cyp26a1 E did not lead to an
apparent impairment in upregulation of Cyp26a1 whereas
the homozygous enhancer knock-out led to a complete
loss of inducibility (Figure 5I). Interestingly, our RNA-seq
data showed RA-inducible expression of two unannotated,
spliced, and poly-adenylated transcripts, located anti-sense
and only a few hundred basepairs upstream of Cyp26a1
(Cyp26a1 as trx1&2). For these enhancer-proximal tran-
scripts we found that RA-induction was impaired in the
heterozygous lines whereas activation was completely lost
in the homozygous Cyp26a1 E deletion clone. Inducibil-
ity of Hoxa1 by RA and expression of OCT4 (Pou5f1),
two genes located on other chromosomes than Cyp26a1 E,
was not affected by the Cyp26a1 E deletion, indicating that
RA-signaling is still functional in the homozygous enhancer
knockout and that the effects observed are specific for tran-
scripts that are enhancer-proximal. For the other investi-
gated enhancer, upstream of the Hoxa gene cluster (Hoxa
E Figure 5H), we were able to generate only heterozygous
deletion mutants (Supplementary Figure S5F). These mu-
tants were still able to activate Hoxa1 and Hoxa4 upon RA
treatment to induce differentiation, however with slightly
reduced levels compared to wildtype indicating that this en-
hancer might contribute to the RA-dependent upregulation
of the Hoxa gene cluster (Figure 5J). The impact of the
Hoxa E deletion was more prominent for the non-coding
RNA Halr1, which is located upstream of the Hoxa genes
and thus closer to the investigated enhancer. Specifically, the
heterozygous deletion of the Hoxa E resulted in a marked
decrease in Halr1 expression during pluripotency and much
lower levels when cells were treated with RA to stimulate
differentiation. In contrast, expression of Skap2, a gene up-
stream of the Hoxa gene cluster, and mESC marker Pou5f1
are not impacted by the Hoxa enhancer deletion, which in-
dicates specificity of the observed effects. Thus, consistent
with the data for the episomal reporter (Figure 5F), this in-
dicates a dual function of this enhancer to facilitate basal
Halr1 expression during pluripotency as well as induced ex-
pression upon differentiation.
Altogether, these results show, that the FAIRE-STARR-
seq assay can be used to trace the dynamics of enhancer ac-
tivity and can be used to identify enhancers which gain, but
also those that loose enhancer activity upon induced differ-
entiation. These enhancer subsets are characterized by dis-
tinct motif enrichments and the binding of specific TFs and
are associated with regulation of nearby genes.
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Sequence features associated with RAR-occupied en-
hancers that change activity upon ligand binding
The quantitative nature of our FAIRE-STARR-seq data
can be used as a resource to study the coupling of tran-
scription factors binding sites and other features to en-
hancer activity. For example, our ChIP-seq experiments
targeting RAR, the receptor of RA and key effector in
RA-induced differentiation, uncovered thousands of bind-
ing sites. However, only a subset of these RAR-occupied
sites show a change in activity upon RA-treatment in our
STARR-seq experiments (Figure 6A). Moreover, depend-
ing on the RAR-occupied region examined, we found that
enhancer activity can either stay the same, go up, or go
down upon addition of RAR’s cognate ligand RA (Fig-
ure 6A and B). To identify sequence features that may play
a role in determining if an RAR-occupied site changes
its activity upon RA treatment, we first determined the ef-
fect of RA treatment on enhancer activity for all RAR-
occupied sites covered in our STARR-seq library (Supple-
mentary Figure S6A). Next, we defined three categories:
Active RAR-occupied enhancers which (i) do not change
activity upon RA treatment (‘non-responding)’, (ii) become
more active upon RA treatment (‘induced’) and finally, (iii)
RAR-occupied enhancers whose activity decreases upon
treatment (‘repressed’, Figure 6B). Comparison of the mo-
tif composition of these three categories of RAR-occupied
enhancers showed several differences that could play a role
in determining if RA treatment induces a change in en-
hancer activity. For example, RAR::RXR heterodimer
motifs (cluster 25) are more enriched for RAR-occupied
regions that are activated in response to RA than either
regions that are not regulated or those with repressed en-
hancer activity (Figure 6C). Furthermore, clustered TF mo-
tifs of nuclear receptors, such as RXRA::VDR (cluster 2)
and PPARG (cluster 41), and motifs for pluripotency fac-
tors (OCT4, SOX2, and NANOG, cluster 18) and SP/KLF
(cluster 28) were more significantly enriched for induced
RAR binding sites. On the other hand, RAR-occupied
sites that lose activity upon RA treatment had the lowest en-
richment of the canonical RAR::RXR heterodimer mo-
tif and were characterized by a relatively high occurrence
of motif clusters ZNF384 (cluster 55), HOXA10 (cluster
22), and CTCF (cluster 48), which could thus play a role
in RAR-dependent repression of enhancer activity. Side-
by-side comparison of inducible, non-responding, and re-
pressed RAR sites showed that RAR occupancy was
comparable for inducible and non-responding regions with
only slightly lower occupancy at repressed sites (Figure 6F).
Interestingly, chromatin accessibility assessed by ATAC
was comparable for induced and repressed RAR-occupied
sites but higher for non-responding sites in pluripotency
and only increased marginally at induced sites upon RA
treatment (Figure 6F). Similarly, H3K27ac enrichment in
pluripotency was lower at inducible and repressed than
at non-responding RAR sites and inducible regions only
reached comparable levels to repressed sites upon RA treat-
ment (Figure 6F). Accordingly, the enrichment of RAR
and H3K27ac at RAR sites did not correlate positively
with RA-inducibility (Supplementary Figure S6E), indicat-
ing that enhancer inducibility of an RAR site cannot sim-
ply be inferred from ChIP enrichment. This further indi-
cates that sequence composition acts as an additional reg-
ulatory layer to control not only if an enhancer changes its
activity but also the direction in which enhancer activity is
modulated upon RA treatment.
RAR typically binds as a heterodimer together with
retinoic X receptor (RXR) to retinoic acid response ele-
ments (RAREs) that can have distinct motif architectures,
depending on cellular background and differentiation stage
(37,75). These motifs share the same consensus hexam-
eric direct repeat (DR) however they differ in terms of
orientation and the spacing between the repeat elements
(76). To elucidate the possible role of different spacings of
the RAR::RXR consensus motif (MA0159.1) on RA-
induced changes in enhancer activity, we constructed dif-
ferent repeat orientations and spacings in silico (DR, ev-
erted (ER) and inverted repeats (IR) of the consensus mo-
tif with spacing from 0 to 8 nucleotides) and compared in-
ducible, non-responsive, and repressed RAR-occupied re-
gions for enrichment of these motifs (Figure 6D). As previ-
ously described (76), we find DR0 to be the most enriched
spacing for RAR-occupied sites for all three enhancer
subgroups (data not shown). Moreover, induced RAR-
occupied regions are more enriched for each of the investi-
gated motif architectures than their repressed counterparts
and display higher abundance of the consensus repeat half-
site (Supplementary Figure S6B) indicating that activation
might be driven by direct RAR binding to its response ele-
ment whereas repression is not. To determine how DR spac-
ing influences RA-dependent regulation of enhancer activ-
ity in mESCs, we cloned single DRs with different spac-
ings, but the same DR sequence into the STARR vector.
Consistent with previous studies (76), we found that acti-
vation was most prominent for the DR5 spacing, indicat-
ing that the ability of RAR to activate enhancers depends
on the spacing of the DRs (Figure 6E). When we flanked
the DR5 element by either an ETS binding site, which was
highly enriched for RA-inducible mESC enhancers (Figure
5D), or a SoxOct motif, we found no clear change in en-
hancer activity for the ETS binding site. In contrast, when
the DR5 element was flanked by the SoxOct motif, we ob-
served an increase in basal enhancer activity and also in
RA-induced activation. This finding indicates a supportive
role of pluripotency factors in the RA-induced enhancer ac-
tivation by RAR and aligns well with the motif enrichment
(Figure 5D) and mutation analyses (Figure 5F) for differ-
entially active enhancers showing that the SoxOct motif is
important for both basal and RA-dependent activation of
RAR-occupied enhancers.
DISCUSSION
This study provides a comprehensive genome-wide en-
hancer activity map in mESCs assessed by FAIRE-STARR-
seq, that can be used as a resource for further dissection
of enhancer function in mESCs, and identifies various se-
quence features associated with enhancer activity.
To understand what discriminates active enhancers from
inactive accessible regions covered by our FAIRE-STARR
library, we compared these two groups and found that ac-
tive regions are characterized by the presence of specific TF






Figure 6. RA-induced changes in enhancer activity at RAR-occupied sites correlate with specific sequence and chromatin features. (A) Genome browser
view of an exemplary genomic region encompassing RA-inducible and non-inducible RAR binding sites. Normalized ATAC-, FAIRE-STARR and RNA-
seq signals for LIF or RA treated cells and RefSeq genes for this region in either black (protein coding genes) or red (non-coding genes). (B) Distribution
of changes in STARR activity (log2 fold change STARR score RA/LIF) and mean STARR activity (log score, for both treatments) of RAR-occupied
regions that are covered in our FAIRE-STARR input library (as shown in Supplementary Figure S6A). Only regions with a minimum mean STARR
activity ≥2.5 were included for further analysis. The 10% most induced, 10% most repressed and an equal number of regions that do not respond to RA
treatment (non-resp.) were used for motif enrichment and TF binding analyses. (C) Enriched TF motif clusters (JASPAR 2018 clustered motif matrices)
at induced, repressed, and non-responsive RAR-occupied sites. TF motif clusters with a maximum E-value of 1e−5 for at least one group and a log fold
change ≥2 of induced or repressed over non-responsive regions are shown. Z-score normalization of E-values per row was performed. (D) Different spacings
(0–8 nucleotides) and orientations (direct (DR), inverted (IR), and everted repeat (ER)) of the RAR::RXR consensus motif (MA0159.1, upper panel,
arrows highlight repeat orientation) were constructed in silico and used for motif enrichment analysis using AME. Only motifs which showed significant
enrichment (E-value ≤ 1e−3) for at least one RAR binding site group are shown. Z-score normalization of E-values per row was performed. (E) Enhancer
activity measured by STARR-RT-qPCR for selected spacing variants of the RAR::RXR consensus motif (MA0159.1) and neighboring TF motifs as
indicated (scr = scrambled motif) after 4 h of LIF or RA treatment. Bar plots depict the mean GFP expression + SE for three biological replicates. (F)
Mean enrichment of RAR and H3K27ac as well as chromatin accessibility (ATAC) at induced, repressed, and non-responsive RAR-occupied sites.
motifs as well as the presence of an overall higher quan-
tity of enriched motifs (Figure 1G). As expected, among
the most prominently enriched motifs for active enhancers
were the motifs of pluripotency factors OCT4, SOX2 and
NANOG (cluster 18) but also SP/KLF and ETS family TFs
(cluster 28 and 7), which are TFs almost ubiquitously ex-
pressed across cell types. Inactive accessible regions showed
fewer enriched motifs. Moreover, these enriched motifs typ-
ically belong to cell-type specific TFs that are not expressed
in mESCs (Supplementary Figure S1F) and are associated
with differentiation. Thus, it might be possible that these
open but inactive regions become active in upon differentia-
tion. Consistent with our findings, a recent study which sys-
tematically analyzed the quantity and composition of TF
motifs for mESC enhancers described a threshold for the
minimal number of TF motifs required for enhancer activity
(61). Additionally, this finding of motifs adding synergisti-
cally to enhancer activity, once passing a threshold of min-
imal number of motifs, could explain the nature of super-
enhancers, regulatory elements that are much larger in size
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(> 12 kb) and show much higher activity than regular en-
hancers. We did not identify such super-enhancers in our
data, but rather individual regions within a super-enhancer
that show high activity, which is in line with previous find-
ings in human ESCs (41).
The introduction of UMIs during the reverse transcrip-
tion step allowed us to efficiently distinguish between in-
dependent transcript replicates and PCR duplicates of
reporter-derived reads and to analyze enhancer activity
quantitatively. When we started our project, UMIs were not
part of the STARR-seq protocol. However, in the meantime
a similar approach has been proposed for low complexity
libraries where UMIs are introduced in the first PCR cy-
cle (53). By applying UMIs, we could not only identify ac-
tive enhancers, but also show that specific sequence features
are associated with activity levels (Figure 2C). For exam-
ple, motifs for SP/KLF (cluster 28) and ETS TFs (cluster
7), which are essentially ubiquitously expressed across cell
types, but also CG-rich motif clusters ZBTB33 (cluster 50),
ZNF143 (cluster 63), ZNF263 (cluster 54), and SPIB (clus-
ter 49) are specifically enriched at highly active enhancers
and could contribute to high enhancer activity in mESCs. In
contrast, motifs for pluripotency TFs (cluster 18) are sim-
ilarly enriched for both highly- and lowly active enhancers
and thus seem required for an enhancer to be active yet not
for specifying its activity level.
Since many of the TFs associated with low enhancer ac-
tivity are not expressed in mESCs, we speculate that these
enhancers are primed for high activity once the specific
TFs are expressed, e.g. at later stages during differenti-
ation to exert their cell-type specific enhancer functions.
The quantitative nature of our assay also allowed us to as-
sess changes in enhancer activity during the early stages
of RA-induced differentiation and to identify enhancers
that gain or lose activity as well as associated and required
TF motifs. As expected, we found that pluripotency TFs
and STAT3 are associated with LIF-dependent enhancer
function, however they are also found at RA-inducible en-
hancers (Figure 5D, Supplementary Figure S5D). Mutation
experiments of individual reporter constructs (Figure 5F)
highlighted the crucial contribution of OCT4 and SOX2
motifs to enhancer activity in pluripotency, RAR::RXR
motif importance for RA-inducible activation, but also
the cooperation of pluripotency and RAR::RXR motifs
in maintaining enhancer activity. Genomic deletion of se-
lected RA-inducible enhancers (Figure 5G–J) further vali-
dated the impact of the identified enhancers on expression
of neighboring genes. Additionally, the quantitative anal-
ysis of RAR binding sites revealed a possible synergis-
tic activation of RA-inducible RAR-bound enhancers by
pluripotency TFs and RAR (Figure 6E). A role of OCT4
in recruiting RAR::RXR to enhancers of differentiation-
associated genes has been demonstrated (77) and together
with our data points towards an additional role of OCT4,
and possibly SOX2, in facilitating increased enhancer activ-
ity during differentiation.
While our FAIRE-STARR-seq approach has the advan-
tage to quantify enhancer activity on a fragment basis and
to reduce the complexity of an investigated input library, it
also has its limitations. For example, the resolution of our
assay is lower when compared to another type of STARR-
seq using accessible chromatin enriched by ATAC (43). Fur-
ther, enhancer activity is measured for populations of cells,
which might mask activity that is restricted to a subset of in-
dividual cells. Finally, the episomal nature of the assay may
not capture various levels of regulation that occur in the en-
dogenous genomic context.
In our study, only a minor fraction of the probed ac-
cessible regions (4765 of 186 959) showed reproducible sig-
nificant enhancer activity. A recent enhancer identification
study based on STARR-seq, assessing activatory potential
of the whole genome, found over 18 500 active enhancers
in mESCs (45). However, the mentioned study assessed a
larger input library and did not remove PCR duplicates
from their analyses, and thus applied less stringent cut-offs
that would lead to similar quantities of active enhancers in
our assay (e.g. we would call 21 thousand active enhancers
without UMI-aware deduplication). A comparison of en-
hancers identified in these two studies reveals that 25.1% of
the active enhancers called for our data in serum/LIF con-
ditions without UMI-deduplicated enhancers coincide with
enhancers that overlap with accessible regions from Peng
et al. Vice versa, 33.9% of their enhancers overlap with our
dataset. The difference between these studies might also be
related to the different promoters of the reporters that were
used in these studies, since differences in promoter-enhancer
compatibility can influence whether an enhancer can acti-
vate a promoter or not (78). Given the different experimen-
tal set-up of these studies, these two enhancer catalogs in
mESCs could complement each other.
When we analyzed the active FAIRE-STARR enhancers,
which we identified by an episomal assay, for the chro-
matin signatures present at their endogenous genomic loci,
we identified that many show the expected signature of ac-
tive enhancers (high H3K4me1/H3K4me3 ratio and high
H3K27ac). In addition, we identified enhancer clusters
which can be classified as poised (no H3K27ac), repressed
(elevated H3K27me3 or H3K9me3) or promoters (higher
H3K4me3 than H3K4me1) based on their chromatin con-
text. Strikingly, we found that almost half of the active en-
hancers are located at gene promoters (defined as the region
up to 1 kb upstream of a TSS, Figure 1F). The identifica-
tion of such E-promoters by FAIRE-STARR-seq is in line
with previous reports of promoters that act as enhancers
for other genes (6–8) and the high percentages of promoter-
proximal enhancers identified by STARR-seq based assays
in other cell types (43,44). Poised enhancers (cluster F) dis-
play enrichment of TF motif cluster 24, which encompasses
TFs ZIC1, ZIC3 and ZIC4. ZIC3 is a critical TF for the
transition from naı̈ve to primed pluripotency (79) and was
shown to activate chromatin-masked enhancers in mESCs,
when taken out of the endogenous context (45). Based on
our data, we expect that that ZIC3, or another TF from
the ZIC family, activates cluster F enhancers during differ-
entiation. Furthermore, we identify a subset of enhancers
(cluster G) which display enrichment of two contradictory
marks: H3K36me3 associated with active transcription and
H3K9me3 which marks repressed chromatin. This combi-
nation of HMs can occur on the same nucleosome (67),
to demark 3′ exons of zinc finger (ZNF) genes which con-
sist of repetitive sequences (Zinc finger (ZNF) domains)
(80,81), and is possibly the result of two independent mech-
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anisms, active transcription (H3K36me3) and ATRX chro-
matin remodeler-mediated preservation of genomic stabil-
ity by repressing recombination between ZNFs (H3K9me3)
(69). We now find ZNF genes to be associated with distal
cluster G enhancers (Figure 3C), which are marked with
the same chromatin signature (Figure 3A). Interestingly,
the vast majority of cluster G enhancers map to endoge-
nous retrovirus-K (ERVK) family repeats (Supplementary
Figure S3F), which possess endogenous enhancer function
in mESCs (28,29). Thus, a similar mechanism that ensures
ZNF gene stability might also play a role in preventing re-
combination between repetitive ERVK elements that serve
as enhancers of these genes.
Motivated by a study claiming that H3K122ac marks a
novel class of enhancers in mESCs (62), we added this HM
to our panel of modifications assayed. However, contrary
to the published study, we did not find an enhancer cluster
demarked by H3K122ac while lacking the H3K27ac mark,
even when we forced k-means clustering to search for more
clusters (data not shown). Rather, we found that H3K122ac
and H3K27ac essentially always co-occur at enhancers. This
also fits with the fact that the same enzymes, histone acetyl-
transferases p300 and CBP, deposit both the H3K27ac and
H3K122ac marks (82,83). The situation is different for a
subset of H3K4me3-marked promoter regions, which have
high H3K122ac levels while H3K27ac levels are relatively
low (Supplementary Figure S3H). Here a possible expla-
nation is that the selective methylation of H3K27 but not
H3K122 at promoter regions by polycomb repressive com-
plex 2 prevents acetylation of H3K27 whereas H3K122
can still be modified. Accordingly, we find that H3K27me3
levels are higher at H3K27ac low, H3K122ac high re-
gions. Taken together, these findings highlight the ability
of STARR-seq to identify enhancers that are most likely
poised for activation or even repressed, when taken out
of the genomic context. These regions, and also promot-
ers, are frequently excluded from enhancer prediction tools.
Conversely, prediction tools like CRUP identify more puta-
tive enhancer regions that lack accessibility (Supplementary
Figure S3G) but could be activated once bound by pioneer-
ing TFs. Thus, STARR-seq and enhancer prediction display
complementary information about enhancers.
In summary, we generated a genome-wide enhancer ac-
tivity map by FAIRE-STARR-seq which catalogs active
regulatory regions in mESCs, in pluripotency and after in-
duced differentiation. We identified features associated with
enhancer activity and regulatory elements which are omit-
ted by standard prediction tools. Our findings can serve as a
reference for future functional studies of the regulatory net-
work of genomic elements in mESCs and contribute to the
refinement of computational methods to predict regulatory
elements.
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CRUP: a comprehensive framework to predict condition-specific
regulatory units. Genome Biol., 20, 227.
24. Silva,J. and Smith,A. (2008) Capturing pluripotency. Cell, 132,
532–536.
25. Young,R.A. (2011) Control of the embryonic stem cell state. Cell,
144, 940–954.
26. Wu,J., Huang,B., Chen,H., Yin,Q., Liu,Y., Xiang,Y., Zhang,B.,
Liu,B., Wang,Q., Xia,W. et al. (2016) The landscape of accessible
chromatin in mammalian preimplantation embryos. Nature, 534,
652–657.
27. Buecker,C., Srinivasan,R., Wu,Z., Calo,E., Acampora,D., Faial,T.,
Simeone,A., Tan,M., Swigut,T. and Wysocka,J. (2014)
Reorganization of enhancer patterns in transition from naive to
primed pluripotency. Cell Stem Cell, 14, 838–853.
28. Sundaram,V., Choudhary,M.N.K., Pehrsson,E., Xing,X., Fiore,C.,
Pandey,M., Maricque,B., Udawatta,M., Ngo,D., Chen,Y. et al.
(2017) Functional cis-regulatory modules encoded by mouse-specific
endogenous retrovirus. Nat. Commun., 8, 14550.
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